![Sung-Bae Cho](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sung-Bae Cho
Algemeen Directeur bij CHOA PHARMACEUTICAL CO., LTD.
Vermogen: 822 293 $ op 31-05-2024
Actieve functies van Sung-Bae Cho
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CHOA PHARMACEUTICAL CO., LTD. | Directeur/Bestuurslid | 17-10-2014 | - |
Algemeen Directeur | 17-10-2014 | - | |
President | 17-10-2014 | - |
Loopbaan van Sung-Bae Cho
Eerdere bekende functies van Sung-Bae Cho
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Medipharm
![]() Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Corporate Officer/Principal | - | - |
Opleiding van Sung-Bae Cho
Hanyang University | Undergraduate Degree |
Statistieken
Internationaal
Zuid-Korea | 4 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Medipharm
![]() Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Beurs
- Insiders
- Sung-Bae Cho
- Ervaring